Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients.
D000293:Adolescent; D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000097:blood*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D013739:Testosterone / Q000097:blood*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D006063:Chorionic Gonadotropin; D001971:Bromocriptine; D013739:Testosterone; D011388:Prolactin